RASGRP4 and diabetes mellitus: These outcomes indicated that the ablation of RasGRP4 could restrain the infiltration and activation of M1 macrophages in the kidneys in settings of diabetic IRI, and hyperglycemia can readily engender a proinflammatory milieu.